Cytokinetics Inc (NASDAQ:CYTK)

7.15
Delayed Data
As of Apr 20
 +0.05 / +0.70%
Today’s Change
6.75
Today|||52-Week Range
17.20
-12.27%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close7.10
Today’s open7.10
Day’s range7.05 - 7.30
Volume165,718
Average volume (3 months)412,618
Market cap$448.3M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-764.10%
Earnings growth (this year)+23.17%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-87.44%
P/E ratioNM
Price/Sales30.12
Price/Book4.08

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.10+0.68%
FLXNFlexion Therapeutics...-0.36-1.43%
ACRSAclaris Therapeutics...+0.13+0.74%
AKBAAkebia Therapeutics ...-0.04-0.43%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateApril 27, 2018
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$13.4M
Annual profit (last year)-$127.8M
Net profit margin-955.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts